Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tevogen Bio Holdings Inc shares valued at $1,768,993 were sold by Saadi Ryan H. on Jun 09 ’25. At $1.23 per share, Saadi Ryan H. sold 1,438,206 shares. The insider’s holdings dropped to 116,814,453 shares worth approximately $148.35 million following the completion of this transaction.
Also, Saadi Ryan H. purchased 1,438,206 shares, netting a total of over 1,582,027 in proceeds.
Before that, Flomenberg Neal had sold 232,968 shares from its account. In a trade valued at $253,935, the insider traded Tevogen Bio Holdings Inc shares for $1.09 each. Upon closing the transaction, the insider’s holdings decreased to 232,968 shares, worth approximately $4.57 million.
As published in their initiating research note from D. Boral Capital on March 04, 2025, Tevogen Bio Holdings Inc [TVGN] has been a Buy and the price target has been revised to $10.
Analyzing TVGN Stock Performance
On last trading session,, Tevogen Bio Holdings Inc [NASDAQ: TVGN] plunged -5.22% to $1.27. The stock’s lowest price that day was $1.255, but it reached a high of $1.355 in the same session. During the last five days, there has been a drop of approximately -9.93%. Over the course of the year, Tevogen Bio Holdings Inc shares have jumped approximately 23.30%.
Support And Resistance Levels for Tevogen Bio Holdings Inc (TVGN)
RSI (Relative Strength Index) is 52.37 on the 14-day chart, showing neutral technical sentiment.
Is Tevogen Bio Holdings Inc subject to short interest?
Stocks of Tevogen Bio Holdings Inc saw a sharp steep in short interest on 2025-05-30 dropping by -1.42 million shares to 1.8 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 3.22 million shares. A decline of -78.82% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.27 of the overall float, the days-to-cover ratio (short ratio) decline to 2.27.
